|
|
|
|
Дата |
|---|
| 02.02.2026 |
| 01.02.2026 |
| 29.01.2026 |
| 28.01.2026 |
| 27.01.2026 |
| 26.01.2026 |
| 22.01.2026 |
| 21.01.2026 |
| 20.01.2026 |
| 19.01.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
65.03
|
64.00
|
65.95
|
64.53
|
|
|
2 708 767.99
|
258.00
|
|
|
|
62.30
|
61.22
|
66.29
|
65.03
|
|
|
16 351 364.65
|
822.00
|
|
|
|
62.26
|
59.21
|
62.80
|
62.30
|
|
|
7 713 413.21
|
344.00
|
|
|
|
62.26
|
59.21
|
62.80
|
62.30
|
|
|
7 713 413.21
|
344.00
|
|
|
|
58.22
|
58.00
|
62.70
|
62.26
|
|
|
6 568 118.71
|
334.00
|
|
|
|
59.32
|
58.00
|
59.75
|
58.22
|
|
|
2 012 934.90
|
207.00
|
|
|
|
59.81
|
59.50
|
60.50
|
59.72
|
|
|
1 532 847.32
|
132.00
|
|
|
|
59.62
|
58.71
|
60.00
|
59.81
|
|
|
2 654 137.11
|
187.00
|
|
|
|
59.96
|
59.31
|
60.50
|
59.62
|
|
|
1 726 685.89
|
108.00
|
|
|
|
58.43
|
58.70
|
60.05
|
59.96
|
|
|
1 506 994.51
|
117.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2022, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2014, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
08.01.2026
|
11.01.2026 |
1 EGP |
|
25.06.2023
|
03.07.2023 |
0.75 EGP |
|
02.01.2023
|
03.01.2023 |
3 EGP |
|
28.08.2020
|
31.08.2020 |
0.5 EGP |
|
01.12.2019
|
02.12.2019 |
0.5 EGP |
|
24.12.2017
|
25.12.2017 |
0.5 EGP |
|
11.11.2016
|
14.11.2016 |
0.5 EGP |
|
08.07.2015
|
09.07.2015 |
0.5 EGP |
|
24.05.2012
|
27.05.2012 |
0.75 EGP |
|
03.06.2011
|
06.06.2011 |
0.75 EGP |
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products.
